Prostate cancer detection after negative biopsy: MRI, biomarker or systematic biopsy

Prostate cancer detection after negative biopsy: MRI, biomarker or systematic biopsy

Bibliographic Details
Main Authors:	D. Cheung, D.E. Magee, A.E. Hird, N. Perlis, A. Finelli, G.S. Kulkarni
Format:	Article
Language:	English
Published:	Elsevier 2020-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168320337654

Similar Items

Serum Adipokines as Predictors for the Outcome of Prostate Biopsies at Early Stage Prostate Cancer Diagnosis
by: Ahmad AE, et al.
Published: (2019-11-01)

FUSION PROSTATE BIOPSY IN PATIENTS WITH PREVIOUS NEGATIVE STANDARD PROSTATE BIOPSY
by: A. A. Keln, et al.
Published: (2018-01-01)

Is Additional Systematic Biopsy Necessary in All Initial Prostate Biopsy Patients With Abnormal MRI?
by: Xueqing Cheng, et al.
Published: (2021-02-01)

Infectious complications after MRI targeted vs systematic transrectal prostate biopsy
by: E.I. Kalalahti, et al.
Published: (2020-07-01)

Systematic and MRI-Cognitive Targeted Transperineal Prostate Biopsy Accuracy in Detecting Clinically Significant Prostate Cancer after Previous Negative Biopsy and Persisting Suspicion of Malignancy
by: Alvydas Vėželis, et al.
Published: (2021-01-01)

Repeat prostate biopsy strategies after initial negative biopsy: meta-regression comparing cancer detection of transperineal, transrectal saturation and MRI guided biopsy.
by: Adam W Nelson, et al.
Published: (2013-01-01)

Adding random systematic biopsies to MRI-fusion targeted prostate biopsy procedures: Always, in selected cases, or never?
by: M.C.A. Bergman, et al.
Published: (2020-07-01)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
by: Jeffrey J Leow, et al.
Published: (2023-01-01)

Can we omit systematic biopsies in patients undergoing MRI fusion-targeted prostate biopsies?
by: Leow, Jeffrey J., et al.
Published: (2023)

Prostate Biopsy: General Consideration and Systematic Biopsy
by: Hyungwoo Ahn
Published: (2023-11-01)

MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies
by: Tahir Durmuş,, et al.
Published: (2013-09-01)

Biomarkers in previous histologically negative prostate biopsies can be helpful in repeat biopsy decision‐making processes
by: Xingbo Long, et al.
Published: (2020-10-01)

Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients
by: Johannes Mischinger, et al.
Published: (2022-10-01)

Indications for a second prostate biopsy in patients suspected with prostate cancer after an initial negative prostate biopsy
by: Kwang Suk Lee, et al.
Published: (2017-03-01)

Serum testosterone as a biomarker for second prostatic biopsy in men with negative first biopsy for prostatic cancer and PSA>4ng/mL, or with PIN biopsy result
by: Alexandros Fiamegos, et al.

Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
by: Nicolette G. Alkema, et al.
Published: (2022-10-01)

Diagnostic performance of micro-ultrasound prostate biopsies in patients undergoing mpMRI-fusion biopsies
by: D. Maffei, et al.
Published: (2020-07-01)

Prostate Biopsy in the Case of PIRADS 5—Is Systematic Biopsy Mandatory?
by: Wojciech Malewski, et al.
Published: (2023-08-01)

The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy
by: G. Gandaglia, et al.
Published: (2020-07-01)

The added value of concomitant systematic biopsy in predicting biochemical recurrence after radical prostatectomy in patients with prostate cancer diagnosed by MRI-targeted biopsy
by: A. Rizzo, et al.
Published: (2020-10-01)

Micro-ultrasound guided and MRI-targeted prostate biopsies for clinically significant prostate cancer diagnosis in the initial biopsy setting a cohort of biopsy-naive patients
by: D. Maffei, et al.
Published: (2020-10-01)

Multiparametric MRI Fusion-Guided Prostate Biopsy for Detection of Clinically Significant Prostate Cancer Eliminates the Systemic Prostate Biopsy
by: Augustinas Matulevičius, et al.
Published: (2022-10-01)

Prostate Biopsy: What is the future of this old Procedure? The Multiparametric Magnetic Resonance Imaging MRI/TRUS fusion prostate biopsy
by: Luciano A. Favorito
Published: (2015-10-01)

Is the MRI-guided prostate biopsy better than systematic biopsy for upgrading in patients under active surveillance (AS)? Systematic review and meta-analysis
by: W. Baccaglini, et al.
Published: (2020-07-01)

Prostate mapping for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining micro-ultrasound and mpMRI fusion biopsy
by: M.E. Rodríguez Socarrás, et al.
Published: (2020-07-01)

Prostate “Mapeo” for cancer diagnosis: The Madrid protocol. Transperineal prostate biopsies combining Micro-ultrasound and mpMRI fusion biopsy.
by: M.E. Rodríguez Socarrás, et al.
Published: (2020-01-01)

The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
by: Chung Un Lee, et al.
Published: (2021-10-01)

Liquid Biopsy Potential Biomarkers in Prostate Cancer
by: Jochen Neuhaus, et al.
Published: (2018-09-01)

Evaluation of the Predictive Role of Blood-Based Biomarkers in the Context of Suspicious Prostate MRI in Patients Undergoing Prostate Biopsy
by: Pawel Rajwa, et al.
Published: (2021-11-01)

Multiparametric Prostate MRI in Biopsy-Naïve Men: A Prospective Evaluation of Performance and Biopsy Strategies
by: Brage Krüger-Stokke, et al.
Published: (2021-10-01)

MRI-Guided Targeted and Systematic Prostate Biopsies as Prognostic Indicators for Prostate Cancer Treatment Decisions
by: Furat Abd Ali, et al.
Published: (2023-08-01)

Concordance of MRI-Guided Fusion and Systematic 12-Core Prostate Biopsy for the Detection of Prostate Cancer
by: Matthew Parsons, et al.
Published: (2022-05-01)

Experience in the use of MRI-ultrasound fusion-targeted biopsy of the prostate for the diagnosis of prostate cancer
by: E. S. Nevirovich, et al.
Published: (2018-10-01)

Adding systematic biopsy (SBx) to magnetic resonance ultrasound fusion targeted biopsy (TBx) of the prostate in men with previous negative biopsy or enrolled in active surveillance programs: A prospective single center, randomized, analysis
by: A. Porreca, et al.
Published: (2020-10-01)

Routine systematic prostate biopsies not replaced by magnetic resonance imaging-targeted biopsy
by: David Gómez-Ortiz, et al.
Published: (2022-10-01)

Micro-ultrasound guided prostate biopsies for clinically significant prostate cancer diagnosis in a cohort of biopsy-naive patients with mpMRI
by: D. Maffei, et al.
Published: (2020-11-01)

Comparison of prostate biopsy with or without pre-biopsy multi-parametric MRI in prostate cancer detection: an observational cohort study
by: Bryant, R, et al.
Published: (2018)

MRI–Ultrasound Fused Approach for Prostate Biopsy—How It Is Performed
by: Jacob Lang, et al.
Published: (2024-04-01)

Liquid Biopsy and Potential Liquid Biopsy-Based Biomarkers in Philadelphia-Negative Classical Myeloproliferative Neoplasms: A Systematic Review
by: Mihnea-Alexandru Găman, et al.
Published: (2021-07-01)

MRI-Targeted or systematic random biopsies for prostate cancer diagnosis in biopsy naïve patients: Follow-up of a precision trial-like retrospective cohort
by: S. Luzzago, et al.
Published: (2020-10-01)